Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness

Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes
                         of Severe Allergy Awareness

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

PR Newswire

BRIDGEWATER, N.J., March 14, 2013

BRIDGEWATER, N.J., March 14, 2013 /PRNewswire/ --If you or your loved one is
at risk for anaphylaxis – a severe, life-threatening allergic reaction – you
probably know the feeling of gratitude you have when someone goes the extra
mile to help with allergen avoidance. Now, there is a new way to say "Thank
You" to someone who has made a difference in the life of an individual at risk
for anaphylaxis. Sanofi US has launched a Severe Allergy Awareness Facebook
page where individuals have a unique opportunity to create online awards via
the "Celebrate Someone" app for those who have helped them or a loved one
manage their severe allergies. For example, an award can celebrate a co-worker
who provided an allergy-friendly food option during a meeting, or a mom who
substituted mylar balloons for latex balloons at a birthday party. 

Awards can recognize individuals, groups, companies or organizations, and for
the first award someone makes, Sanofi US will donate $5 to a patient advocacy
group focused on severe allergies – up to $100,000 in total. The donations
will benefit Food Allergy Research & Education (FARE), Kids with Food
Allergies Foundation (KFA) and the Asthma and Allergy Foundation of America
(AAFA).

"This initiative not only raises understanding of severe allergies and the
risk for anaphylaxis, but it's also a way for us to help several of the
advocacy groups continue the work that they do to provide allergy education
and awareness," said Bryan Downey, Vice President, Anaphylaxis Solutions,
Sanofi US. "We encourage everyone who appreciates the support they've received
for themselves or a family member to show their appreciation and nominate
someone for the Severe Allergy Awareness Hall of Fame." 

Up to six million Americans may be at risk for anaphylaxis, although the
precise incidence is unknown and likely underreported.  Numerous studies
indicate that the rate of anaphylaxis has increased in recent years, pointing
to the need for greater awareness.

It is critical that not only the individuals at risk for anaphylaxis and their
immediate family members are aware of their allergens and how to help prevent
severe allergic reactions, but that others in their community are as well,
including teachers, friends, coaches and co-workers.

"As a physician and someone at risk for anaphylaxis myself, I can tell you
first-hand how reassuring others' awareness about my severe allergies can be,"
said Dr. Vivian Hernandez-Trujillo, a pediatric allergist, national expert in
anaphylaxis and consultant to Sanofi US. "There are a number of people in my
life who work to help ensure that I'm safe from my allergens and I look
forward to recognizing them."

"Like" us today at www.facebook.com/severeallergyawareness and visit the
"Celebrate Someone" app to create an award. 

About Anaphylaxis

Anaphylaxis (pronounced ana-fuh-lax-is) is a severe, life-threatening allergic
reaction that happens quickly and may cause death.  Life-threatening allergic
reactions may occur as a result of exposure to allergens including foods such
as peanuts, tree nuts, fish, shellfish, dairy, eggs, soy and wheat; insect
stings; latex and medication, among other allergens and causes. Food is the
most commonly identified anaphylaxis trigger and accounts for 30 percent of
all anaphylaxis fatalities.

The signs and symptoms of anaphylaxis can vary from person to person and from
one episode to the next. Some people may have hives/itching, facial or tongue
swelling, which makes it difficult to breath or swallow, while others may
experience nausea and vomiting. These symptoms may begin within seconds,
minutes or hours after exposure to the allergen.  The best prevention method
of anaphylaxis is avoidance of the specific allergen(s). If anaphylaxis does
occur and if treatment is not administered, the reaction can result in death
within a matter of minutes.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, rare diseases, consumer
healthcare, emerging markets and animal health. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi is the holding company of a consolidated group of subsidiaries and
operates in the United States as Sanofi US, also referred to as sanofi-aventis
U.S. LLC. For more information on Sanofi US, please visit http://www.sanofi.us
or call 1-800-981-2491.

SOURCE Sanofi US

Website: http://www.sanofi.us
Website: http://www.facebook.com/severeallergyawareness
Contact: Sanofi US: Lindsey Schedler, +1-908-981-6754,
Lindsey.Schedler@Sanofi.com; Lori Lukus, +1-908-981-3876,
Lori.Lukus@Sanofi.com
 
Press spacebar to pause and continue. Press esc to stop.